FindTrial
Sign In

Cervical cancer screening using HPV self sampling method

Scaling up of implementation of primary HPV screening by self-sampling

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029419
Enrollment
6000
Registered
2020-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Primary screening for cervical cancer using HPV testing: Women aged between 30 to 65 years will be screened using HPV test Control Intervention1: Not applicable: Not applicable

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women between 30 and 65 years of age and residing in the selected areas of the East district will be included

Exclusion criteria

Exclusion criteria: 1. Women suffering from debilitating illnesses 2. Pregnant women

Design outcomes

Primary

MeasureTime frame
Increased access and coverage of screening in the eligible population by 30%.Timepoint: 3 years—

Secondary

MeasureTime frame
Increased detection of cervical intraepithelial neoplasia lesions by 20%Timepoint: 3 years—

Countries

India

Contacts

Public ContactDr Roopa Hariprasad

ICMR-NICPR

roopaicmr@gmail.com09818278797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026